input: [CGS §] 38a-483c 38a-513b [Mandate] Experimental Treatments [Individual, Group, or Both] Both [Description] 
output: Procedures, treatments, or drugs that have completed a Phase III Food and Drug Administration clinical trial. Appeals process expedited for those with a life expectancy of less than two years.